Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Thomassen

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
European Stroke Journal|September 9, 2022
Vascular risk factors and staging of atherosclerosis in patients and controls: The Norwegian Stroke in the Young StudyBeenish Nawaz, Annette Fromm, Halvor Øygarden, et al.
European Stroke Journal|March 28, 2022
Prevalence of atherosclerosis and association with 5-year outcome: The Norwegian Stroke in the Young StudyBeenish Nawaz, Annette Fromm, Halvor Øygarden, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 8, 2025
Association between blood pressure and outcome in patients with acute ischemic stroke treated with alteplaseOle Morten Rønning, Linn Nordby, Nicola Logallo, et al.
European Journal of Neurology|September 26, 2021
Sex differences in the Norwegian Tenecteplase Trial (NOR-TEST)Håkon Ihle-Hansen, Else Charlotte Sandset, Hege Ihle-Hansen, et al.
BMC Neurology|July 12, 2015
A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS)Aliona Nacu, Christopher E Kvistad, Nicola Logallo, et al.
The New England Journal of Medicine|September 14, 2017
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic StrokeLars Søndergaard, Scott E Kasner, John F Rhodes, et al.
BMC Neurology|June 3, 2014
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic strokeNicola Logallo, Christopher E Kvistad, Aliona Nacu, et al.
Stroke|August 17, 2004
Underfunding of stroke research: a Europe-wide problemSarah T Pendlebury, Peter M Rothwell, Ale Algra, et al.
BMC Neurology|July 20, 2013
The Norwegian Stroke in the Young Study (NOR-SYS): rationale and designAnnette Fromm, Lars Thomassen, Halvor Naess, et al.
The Lancet. Neurology|May 7, 2022
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trialChristopher Elnan Kvistad, Halvor Næss, Bernt H Helleberg, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
European Stroke Journal|September 9, 2022
Vascular risk factors and staging of atherosclerosis in patients and controls: The Norwegian Stroke in the Young StudyBeenish Nawaz, Annette Fromm, Halvor Øygarden, et al.
European Stroke Journal|March 28, 2022
Prevalence of atherosclerosis and association with 5-year outcome: The Norwegian Stroke in the Young StudyBeenish Nawaz, Annette Fromm, Halvor Øygarden, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|December 8, 2025
Association between blood pressure and outcome in patients with acute ischemic stroke treated with alteplaseOle Morten Rønning, Linn Nordby, Nicola Logallo, et al.
European Journal of Neurology|September 26, 2021
Sex differences in the Norwegian Tenecteplase Trial (NOR-TEST)Håkon Ihle-Hansen, Else Charlotte Sandset, Hege Ihle-Hansen, et al.
BMC Neurology|July 12, 2015
A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS)Aliona Nacu, Christopher E Kvistad, Nicola Logallo, et al.
The New England Journal of Medicine|September 14, 2017
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic StrokeLars Søndergaard, Scott E Kasner, John F Rhodes, et al.
BMC Neurology|June 3, 2014
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic strokeNicola Logallo, Christopher E Kvistad, Aliona Nacu, et al.
Stroke|August 17, 2004
Underfunding of stroke research: a Europe-wide problemSarah T Pendlebury, Peter M Rothwell, Ale Algra, et al.
BMC Neurology|July 20, 2013
The Norwegian Stroke in the Young Study (NOR-SYS): rationale and designAnnette Fromm, Lars Thomassen, Halvor Naess, et al.
The Lancet. Neurology|May 7, 2022
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trialChristopher Elnan Kvistad, Halvor Næss, Bernt H Helleberg, et al.
Pageof 14